BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7743237)

  • 1. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee.
    Hays DM; Raney RB; Wharam MD; Wiener E; Lobe TE; Andrassy RJ; Lawrence W; Johnston J; Webber B; Maurer HM
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):46-52. PubMed ID: 7743237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma.
    Lobo S; Gaze MN; Slater O; Hoskin P; Sands G; Sullivan T; Cho A; Eminowicz G; Smeulders N
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29574. PubMed ID: 35044080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
    Wolden SL; Lyden ER; Arndt CA; Hawkins DS; Anderson JR; Rodeberg DA; Morris CD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1071-6. PubMed ID: 26581144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
    Bisogno G; Fuchs J; Dasgupta R; Ferrari A; Haduong JH; Rogers T; Walterhouse DO; Coppadoro B; Xue W; Vokuhl C; Hawkins DS; Seitz G; Merks JHM; Sparber-Sauer M; Venkatramani R
    Cancer; 2022 Dec; 128(23):4150-4156. PubMed ID: 36250420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective study of 70 cases with the head and neck non-parameningeal rhabdomyosarcoma].
    Zhang G; Wang SC; Su Y; Liu ZK; Yu GX; Zhang J; Mei L; Sun N; Li YZ; Zhang XX; Liu QY; Liu ZY; Li XD; Ni X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Feb; 59(2):133-139. PubMed ID: 38369791
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of Perirectal Hyaluronic Acid Spacer Prior to Radiotherapy in a Pediatric Patient With Bladder Rhabdomyosarcoma: A Case Report.
    Arceo-Olaiz R; Smith EA; Stokes C; Eaton BR; Garcia-Roig M
    Urology; 2023 Nov; 181():136-140. PubMed ID: 37453583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local Treatment of Children Suffering From Parameningeal Rhabdomyosarcoma: A Retrospective Single-Center Study From China.
    Peng X; Xiong X; Li Y; Li C; Wang Z; Wu Y; Su M; Weng W; Huang K; Zhou D; Fang J
    Cancer Control; 2024; 31():10732748241240655. PubMed ID: 38514935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Sparber-Sauer M; Dietzschold M; Schönstein A; Heinz A; Vokuhl C; Pajtler KW; Harrabi S; Lin YL; Kalle TV; Hagen R; Ladenstein R; Kazanowska B; Ljungman G; Klingebiel T; Ebinger M; Koscielniak E; Münter M; Timmermann B;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30742. PubMed ID: 37880926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma.
    Esnaola NF; Rubin BP; Baldini EH; Vasudevan N; Demetri GD; Fletcher CD; Singer S
    Ann Surg; 2001 Aug; 234(2):215-23. PubMed ID: 11505068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity.
    Kube P; Parisio K; Mangum DS; Powell J
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36038153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of combining temsirolimus to vincristine, dactinomycin, cyclophosphamide, and vincristine and irinotecan chemotherapy for children with intermediate-risk rhabdomyosarcoma: A report from Children's Oncology Group.
    Oberoi S; Qumseya A; Xue W; Harrison DJ; Rudzinski ER; Wolden SL; Dasgupta R; Venkatramani R; Gupta AA
    Pediatr Blood Cancer; 2023 May; ():e30436. PubMed ID: 37243336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics, treatment, prognosis and pregnancy outcomes in rhabdomyosarcoma of the uterine cervix: a case series.
    Yu X; Qie M; Huang L; Hou M
    Ginekol Pol; 2023 Dec; ():. PubMed ID: 38126889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients.
    Shalaby N; Zaki HF; Badary OA; Kamal S; Nagy M; Makhlouf D; Elnashar A; Elnadi E; Abdelshafi SA; Abouelnaga S; Saber MM
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1391-1409. PubMed ID: 38680001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related toxicity in patients with rhabdomyosarcoma: a report from the children's oncology group.
    Altaf S; Enders F; Lyden E; Donaldson SS; Rodeberg D; Arndt C
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):599-604. PubMed ID: 24936741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD56-chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report.
    Jiang C; Zhao W; Qin M; Jin M; Chang L; Ma X
    Medicine (Baltimore); 2019 Oct; 98(43):e17572. PubMed ID: 31651858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study.
    Slater O; Gains JE; Kelsey AM; De Corti F; Zanetti I; Coppadoro B; Jorgensen M; Gallego S; Orbach DH; Glosli H; Cesen M; Gaze MN; Smeulders N; Ferrari A; Jenney M; Minard-Colin V; Bisogno G; Merks JHM;
    Eur J Cancer; 2022 Jan; 160():206-214. PubMed ID: 34865946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide.
    McNally A; Rossanese M; Suárez-Bonnet A; Hardas A; Yale AD
    J Vet Intern Med; 2023; 37(4):1488-1492. PubMed ID: 37381579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary breast rhabdomyosarcoma in a 17-year-old girl.
    Singotia L; Haritha VS
    J Cancer Res Ther; 2023 Oct; 19(7):2070-2071. PubMed ID: 38376322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case series of urinary bladder rhabdomyosarcoma in seven dogs.
    Pierini A; Criscuolo MC; Caccamo R; Bottero E; Campanile A; Pisani G; Marchetti V; Benvenuti E
    Open Vet J; 2023 Nov; 13(11):1498-1503. PubMed ID: 38107227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abol-Enein pouch modification after radical cystectomy in bladder rhabdomyosarcoma in 5 years old child during COVID-19 pandemic: A case report.
    Ginting JT; Sigumonrong Y
    Int J Surg Case Rep; 2022 Jan; 90():106701. PubMed ID: 34956826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.